Explore more publications!
Anguilla Healthcare Digest
Got News to Share?

Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 16, 2025

MediBeacon® Next Generation TGFR™ System Receives FDA Approval
December 16, 2025

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

Indeterminate GlobeNewswire
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 16, 2025

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

Indeterminate GlobeNewswire
Starton Therapeutics to Present at Biotech Showcase 2026
December 16, 2025

Starton Therapeutics to Present at Biotech Showcase 2026

Indeterminate GlobeNewswire
Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic
December 16, 2025

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic

Indeterminate GlobeNewswire
Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
December 16, 2025

Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)

Indeterminate GlobeNewswire
Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement
December 16, 2025

Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement

Indeterminate GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
December 16, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Indeterminate GlobeNewswire
Elicio Therapeutics Reports Inducement Grants
December 16, 2025

Elicio Therapeutics Reports Inducement Grants

Indeterminate GlobeNewswire
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 16, 2025

Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 16, 2025

Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace

Indeterminate GlobeNewswire
Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards
December 16, 2025

Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards

Indeterminate GlobeNewswire
Annovis to Host Corporate Update Webinar on January 28, 2026
December 16, 2025

Annovis to Host Corporate Update Webinar on January 28, 2026

Indeterminate GlobeNewswire
Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital
December 16, 2025

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Indeterminate GlobeNewswire
MediBeacon® Next Generation TGFR™ System Receives FDA Approval
December 16, 2025

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

Indeterminate GlobeNewswire
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
December 16, 2025

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

Indeterminate GlobeNewswire
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
December 16, 2025

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

Indeterminate GlobeNewswire
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
December 16, 2025

Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

Indeterminate GlobeNewswire
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
December 16, 2025

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

Indeterminate GlobeNewswire
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
December 16, 2025

Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas

Indeterminate GlobeNewswire
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
December 16, 2025

Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions